PCN18 Matching-Adjusted Indirect Comparison (MAIC) of Entrectinib Versus Crizotinib in Patients with ROS1 NON-SMALL CELL LUNG Cancer (NSCLC): An Updated Analysis
Autor: | M. Antoniou, A. Aziez, S. Batson, P. Chu, C.R. Mitchell |
---|---|
Rok vydání: | 2020 |
Předmět: |
Oncology
medicine.medical_specialty Matching (statistics) Crizotinib business.industry Health Policy Public Health Environmental and Occupational Health non-small cell lung cancer (NSCLC) Entrectinib medicine.disease Indirect comparison Internal medicine ROS1 medicine In patient business medicine.drug |
Zdroj: | Value in Health. 23:S423-S424 |
ISSN: | 1098-3015 |
Databáze: | OpenAIRE |
Externí odkaz: |